The study, published Tuesday in The Lancet Oncology, focused on women under 55 with and without a uterus. CBS News medical ...

A new radiotracer developed at the University of Alberta and soon to be tested in human clinical trials in Europe could make ...

South Dakota's All Women Count program provides early detection cancer screenings for over 1,500 low-income women.

Federal budget cuts to the National Institutes of Health and others are affecting graduate students at Cold Spring Harbor Lab ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

In 2022, there were 2.3 million women diagnosed with breast cancer and 670,000 deaths worldwide, according to the World ...

Breast cancer, particularly triple-negative breast cancer (TNBC), remains a leading cause of cancer-related mortality due to ...

Breast cancer is one of the most common cancers among women in the United States. Thanks to decades of fundamental research, ...

A new discovery by the Cold Spring Harbor Laboratory could help point toward the first effective therapy for triple-negative breast cancer. Triple-negative breast cancer accounts for 10 to 15% of all ...

Panelists discuss the rapidly evolving endocrine treatment landscape in oncology, emphasizing the shift toward personalized ...

The relationship between hormone therapy (oestrogen with or without progestogen) and breast cancer risk has been widely ...

AstraZeneca wants to make its oral selective oestrogen receptor degrader (SERD) drug camizestrant a go-to frontline therapy for HR-positive breast cancer, and made its case at ASCO with data from ...